To study the effects of two different drugs for blood pressure control in women immediately after delivery

Phase 4

• Conditions: Health Condition 1: O10-O16- Edema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

• Registration Number: CTRI/2021/04/033252
• Lead Sponsor: Internal Fluid Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

•Postnatal women with new onset hypertension( blood pressure >= 140 mm Hg systolic or >=90mmHg diastolic)

•Women who had been diagnosed with intrapartum hypertension, treated with single short acting antihypertensive , during postnatal monitoring found to have blood pressure >= 140 mm Hg systolic or >=90mmHg diastolic.

•Women who had been on single antihypertensive before pregnancy which was stopped postnatally and later detected to have hypertension after the wash out period of first drug.

Exclusion Criteria

•Women with severe intrapartum hypertension or gestational hypertension requiring >=1 antihypertensives.

•Women who were already on antihypertensive drugs antenatally and the same continued postnatally

•Women with creatinine >1.4 mg/dl

•Women with urine output <100 ml in 4 hours

•Women with known heart block, cardiac failure or heart rate <60 bpm

•Allergy to labetalol or enalapril

•Moderate, persistent or severe asthma

•Women with hyperkalemia

Study & Design

• Study Type: Interventional
• Study Design: Not specified